The Penicillins and Streptomycins dosage market in Guatemala saw fluctuating growth from 2013 to 2023. By 2023, it reached a value of $39.329 million USD. Growth was especially notable from 2015 to 2021, including a significant increase in 2015 and consistent rises post-2019. However, 2022 experienced a downturn, followed by a mild recovery in 2023. The Compound Annual Growth Rate (CAGR) over the last five years stood at 2.87%, reflecting moderate overall market expansion.
Future trends to watch for:
- Impact of global antibiotic resistance initiatives on demand.
- Potential market shifts due to evolving healthcare policies.
- Technological advancements influencing production and distribution.
- Economic factors affecting market dynamics and pricing strategies.
How does Guatemala rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 20 | 20 Portugal | 50,167,000 | 2023 | +0.83% | -0.0056% | View data |
| 21 | 21 Switzerland | 49,944,000 | 2023 | -1.64% | -1.63% | View data |
| 22 | 22 Guatemala | 39,329,000 | 2023 | +2.5% | +2.87% | |
| 23 | 23 Bolivia | 29,241,000 | 2023 | +3.73% | +6.7% | View data |
| 24 | 24 El Salvador | 26,131,000 | 2023 | +1.87% | +2.32% | View data |
